Live Nation To Proceed With Acquisition Of Controlling Interest In OCESA – Quick Facts

Matinas BioPharma Reports Positive Data From First Half Of EnACT Study – Quick Facts

Matinas BioPharma Holdings, Inc. (MTNB) reported positive efficacy and safety data from the first two cohorts of patients in the ongoing EnACT study of MAT2203 for the treatment of cryptococcal meningitis. In Cohort 2, overall survival was 95% in 40 patients randomized to receiving MAT2203.

The EnACT independent Data and Safety Monitoring Board completed a pre-specified review of available safety and efficacy data from Cohort 2 and recommended progression to the second half of the study.

Shares of Matinas BioPharma were up 9% in pre-market trade on Monday.

Oil Prices Jump On Supply Concerns

Oil prices rose over 1 percent on Monday amid concerns over U.S. supplies due to the impact of Hurricane Ida.

About three-quarters of the offshore oil production in the Gulf of Mexico, or about 1.4 million barrels per day, has remained halted since late August.

Last week’s EIA data showing declines in crude oil, gasoline and distillate stockpiles in the U.S. also supported oil’s advance.

Benchmark Brent crude futures climbed 83 cents, or 1.1 percent, to $73.75 a barrel, while U.S. West Texas Intermediate (WTI) crude futures were up 89 cents, or 1.3 percent, at $70.61.

Hurricane Ida had a larger impact on oil production than on refinery demand, causing a net “bullish” impact on U.S. and global storage levels, Goldman Sachs said in a report.

The investment bank described the hit to U.S. output as “historically large” and expects almost 40 million barrels of crude production to be lost, with challenges restarting the Mars stream likely until mid-October.

Later today, OPEC is scheduled to release its latest monthly assessment of worldwide supply and demand.

Pre-market Movers: ITMR, FAMI, VALN, CYRN, LPTX…

The following are some of the stocks making big moves in Monday’s pre-market trading (as of 5.45 A.M. EDT).

In the Green

Itamar Medical Ltd. (ITMR) is up over 42% at $29.51

Cyren Ltd. (CYRN) is up over 28% at $0.77

Leap Therapeutics, Inc. (LPTX) is up over 22% at $1.79

Grupo Supervielle S.A. (SUPV) is up over 18% at $2.93

Grupo Financiero Galicia S.A. (GGAL) is up over 17% at $12.37

Hepion Pharmaceuticals, Inc. (HEPA) is up over 16% at $1.94

Central Puerto S.A. (CEPU) is up over 11% at $3

Document Security Systems, Inc. (DSS) is up over 11% at $1.51

Aterian, Inc. (ATER) is up over 11% at $13.15

Uranium Royalty Corp. (UROY) is up over 10% at $3.85

Banco Macro S.A. (BMA) is up over 8% at $19.80

In the Red

Farmmi, Inc. (FAMI) is down over 33% at $0.38

Valneva SE (VALN) is down over 33% at $31.01

U.S. Well Services, Inc. (USWS) is down over 13% at $0.66

Dynavax Technologies Corporation (DVAX) is down over 13% at $15.10

China XD Plastics Company Limited (CXDC) is down over 8% at $0.50

Walmart says crypto payments announcement is fake. Litecoin tumbles after spike

Cryptocurrency litecoin gave up a 20% gain and tumbled back to earth following a fake press release sent out by GlobeNewswire that referenced a partnership with Walmart.

Walmart spokesman Randy Hargrove confirmed the press release is not authentic and said the company has been in touch with the newswire company to investigate how the false press release got posted. Litecoin last traded down by 2%, according to Coin Metrics.

A number of media organizations including CNBC sent headlines on the announcement. Shares of Walmart had little movement on it.

The announcement referenced a non-working website in the email of one of the contacts listed, raising suspicions.

The news release said that Walmart, the biggest retailer in the U.S., would accept cryptocurrency for payments from shoppers, utilizing litecoin. The release was never listed on Walmart's official corporate website and has been removed from the GlobeNewswire website.

This is a developing story. Check back for updates.

33K New COVID Cases, 279 Deaths In US

With 33807 new cases of coronavirus infections reporting in the United States on Sunday, the national total has increased to 40,955,260, as per the latest data from Johns Hopkins University.

279 additional casualties took the national COVID death toll to 659,975.

As usual, Sunday’s lower metrics are attributed to reporting delays on holidays.

California reported the most number of cases – 73,92 – at the weekend while Texas reported most COVID-related deaths – 136.

California is the worst affected state in terms of both the COVID metrics, with 4484,046 cases and a total of 67,218 people dying due to the disease there.

1620,212 tests were conducted nationally on Sunday, according to data compiled by New York Times.

The number of people hospitalized due to coronavirus infection in the country has slightly fallen, to 100,995.

31,871,868 people have so far recovered from the disease in the country.

As per the latest data published by the Centers for Disease Control and Prevention, a total of 178,692,875 people in the United States, or 53.8 percent of the population, have been fully vaccinated against the coronavirus. This includes 82.5 percent of people above 65.

209,437,152 people, or 63.1 percent of the population, have received at least one dose.

A total of 380,241,903 vaccine doses have been administered so far nationally.

Live Nation To Proceed With Acquisition Of Controlling Interest In OCESA – Quick Facts

Live Nation Entertainment (LYV) has agreed to proceed with its acquisition of a 51% controlling interest in OCESA Entretenimiento for an aggregate purchase price of approximately $444 million, 7% of which will be held back and retained by the company to cover operating losses, if any, for a period of time following closing.

The deal, previously announced in July of 2019, was paused due to the pandemic, and is now anticipated to close by late 2021 or early 2022.

Live Nation is considering various options to finance the purchase price, which include the issuance of equity securities.